Analyzing OneMedNet (NASDAQ:ONMDW) & Aclarion (NASDAQ:ACON)

Aclarion (NASDAQ:ACON) and OneMedNet (NASDAQ:ONMDW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Profitability

This table compares Aclarion and OneMedNet’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aclarion	-10,948.81%	-59.34%	-56.12%
OneMedNet	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings and recommmendations for Aclarion and OneMedNet, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	1	0	1	0	2.00
OneMedNet	0	0	0	0	0.00

Aclarion presently has a consensus price target of $7.50, suggesting a potential upside of 182.38%. Given Aclarion’s stronger consensus rating and higher possible upside, equities analysts plainly believe Aclarion is more favorable than OneMedNet.

Institutional and Insider Ownership

7.5% of Aclarion shares are owned by institutional investors. 0.0% of Aclarion shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Aclarion and OneMedNet”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$80,000.00	95.62	-$7.23 million	($7.40)	-0.36
OneMedNet	$1.46 million	N/A	N/A	N/A	N/A

OneMedNet has higher revenue and earnings than Aclarion.

Summary

Aclarion beats OneMedNet on 5 of the 9 factors compared between the two stocks.

About Aclarion

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.